UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8‑K/A
(Amendment No. 1)
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
September 13, 2018
INOGEN, INC.
(Exact name of registrant as specified in its charter)
|
Delaware |
|
001-36309 |
|
33-0989359 |
|
(State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
326 Bollay Drive
Goleta, California 93117
(Address of principal executive offices, including zip code)
(805) 562-0500
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
Item 5.02. |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
This Amendment No. 1 on Form 8-K/A amends the Current Report on Form 8-K filed by the registrant on September 17, 2018 (the “Original 8-K”), to correct certain typographical errors contained in the “Number of Unvested Shares as of 1/2/2019 (assuming continued employment through such date)” column of Schedule A of the Transition Agreement filed as an exhibit to the Original 8-K. The corrected version of Schedule A is included in the copy of the agreement filed as an exhibit hereto. Other than correcting the typographical errors, all other information included in the Original 8-K is unchanged. Attached as Exhibit 10.1 and incorporated herein by reference is a copy of the Transition Agreement with the typographical errors in Schedule A corrected.
|
Item 9.01. |
Financial Statements and Exhibits. |
(d) Exhibits
|
Exhibit |
|
Description |
|
|
|
|
|
10.1 |
|
Transition Agreement and Release by and between the Company and Matthew Scribner, dated September 14, 2018. |
|
Exhibit No. |
|
Description |
|
|
|
|
|
10.1 |
|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
INOGEN, INC. |
|
|
|
|
|
|
Date: September 18, 2018 |
By: |
/s/ Alison Bauerlein |
|
|
|
Alison Bauerlein Executive Vice President, Finance, Chief Financial Officer, Secretary and Treasurer |